Aramark: Q4 Earnings Insights

Aramark (NYSE:ARMK) reported its Q4 earnings results on Tuesday, November 14, 2023 at 06:30 AM. Here’s what investors…

Aramark (NYSE:ARMK) reported its Q4 earnings results on Tuesday, November 14, 2023 at 06:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Aramark reported in-line EPS of $0.64 versus an estimate of $0.64.

Revenue was up $512.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 1.57% increase in the share price the next day.

Here’s a look at Aramark’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.33 0.26 0.43 0.49
EPS Actual 0.36 0.28 0.44 0.48
Revenue Estimate 4.57B 4.39B 4.55B 4.09B
Revenue Actual 4.75B 4.60B 4.60B 4.39B

To track all earnings releases for Aramark visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Scilex Holding Company Releases Preliminary Unaudited Financial Results For Gross And Net Sales For The Year Ended December 31, 2023; Total Product Gross Sales Were In The Range Of $150M-$155M; Total Product Net Sales Were In The Range Of $46.5M-$52.5M

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute

SCLX